Johnson Pharmacare Financial Statements
Johnson Pharmacare financial statements. In FYNone, Johnson Pharmacare (JOHNPHARMA) reported revenue ₹2 Cr, net profit ₹-57 Cr and EPS ₹-1.00. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Read JOHNPHARMA dividend yield for the complete payout history and dividend yield track record.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
JOHNPHARMA Revenue, Net Profit & EBITDA — Year-on-Year Growth
JOHNPHARMA YoY (March 2026 vs Period), net profit -1.8%, EBITDA +3.5%. Analyse Johnson Pharmacare ownership structure to track promoter, FII and institutional holdings.
JOHNPHARMA Income Statement — Revenue, EBITDA & Net Profit
Johnson Pharmacare revenue ₹2 Cr, EBITDA ₹-55 Cr, net profit ₹-57 Cr, EPS ₹-1.00 (None). For live price, earnings ratios and company overview, see Johnson Pharmacare screener.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 0 | 0 | 0 | 3 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 57 | 57 | 1 | 0 | 4 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| EBITDA | -55 | -57 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit Margin % | 0.00% | 0.00% | 0.00% | 0.00% | -53.00% | 4.00% | 0.00% | 0.00% | -1.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -57 | -56 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -57 | -56 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | -1.00 | -1.01 | -0.01 | 0.00 | -0.02 | 0.00 | 0.00 | -0.02 | 0.00 | -0.01 | -0.02 | -0.03 | -0.01 |
JOHNPHARMA Balance Sheet — Assets, Liabilities & Shareholders' Equity
JOHNPHARMA total assets ₹22 Cr, total equity ₹0 Cr, total liabilities ₹ Cr (2026).
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 22 | 58 | 60 | 60 | 60 | 60 | 59 | 60 | 60 | 59 | 59 | 60 |
| Current Assets | 2 | 1 | 0 | 0 | 1 | 6 | 5 | 5 | 4 | 4 | 22 | 4 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 42 | 46 | 46 | 54 | 52 | 52 | 53 | 54 | 54 | 8 | 0 |
| Other Assets | 0 | 16 | 14 | 14 | 6 | 7 | 7 | 7 | 6 | 5 | 51 | 60 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 21 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 0 | 56 | 57 | 57 | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 59 |
| Share Capital | 55 | 55 | 55 | 55 | 55 | 50 | 50 | 50 | 50 | 50 | 50 | 50 |
| Reserves & Surplus | -55 | 1 | 2 | 2 | 3 | 8 | 8 | 8 | 8 | 8 | 8 | 9 |
JOHNPHARMA Cash Flow Statement — Operating, Investing & Financing
Johnson Pharmacare operating cash flow ₹-2 Cr, investing ₹3 Cr, financing ₹-1 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | 0 | 0 | 5 | 0 | 0 | -1 | -1 | 11 | -11 | 8 |
| Investing Activities | 3 | 0 | -1 | -5 | 0 | 1 | 1 | 0 | -11 | 11 | 10 |
| Financing Activities | -1 | 0 | 1 | 0 | 0 | -1 | 0 | 1 | 0 | 0 | 2 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21 |